-
Name:Telaprevir
Catalog No.:B0008
Structure:
Chemical Properties Cas No.:402957-28-2 Purity Limit: Synonyms: Molecular Weight:679.41 Formula:C36H53N7O6 Storage: Solubility:
Shipping Condition
Quality Control & MSDS
Description Telaprevir (VX-950), marketed under the brand names Incivek and Incivo, is a pharmaceutical drug for the treatment of hepatitis C co-developed by Vertex Pharmaceuticals and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors. Specifically, telaprevir inhibits the hepatitis C viral enzyme NS3.4A serine protease. Telaprevir is only indicated for use against hepatitis C genotype 1 viral infections and has not been proven to have an effect on or being safe when used for other genotypes of the virus. The standard therapy of pegylated interferon and ribavirin is less effective on genotype 1. The cost of telaprevir-based triple therapy for hepatitis C is $189,000 per sustained viral response
References Related products
- Ixazomib
- Odanacatib
- L685458
- Emricasan
- Belnacasan
- Cobicistat
- Ispinesib
- Carfilzomib
- Talabostat
Tel: +86-411-39042497
sales@alphabiopham.com
Contact us now!
We'll offer you the best prices